Allergan (AGN) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
Go back to Allergan (AGN) Tops Q2 EPS by 1c
August 9, 2016 9:08 AM EDT
Piper Jaffray maintained a Neutral rating on Allergen (NYSE: AGN), and cut the price target to $227.00 (from $236.00), following the company's 2Q earnings report. AGN reported non-GAAP diluted EPS of $3.35 on revenue of $3.68B, compared to Street estimates of $3.33 and $3.97B, respectively.
Analyst David Amsellem commented, "Allergan... More
August 8, 2016 9:21 AM EDT
Allergan's (NYSE: AGN) CEO said the company isn't focused on or looking at large deals.
Traders are watching shares of rumored target Biogen (NASDAQ: BIIB) following the comments.
...
More
August 8, 2016 6:18 AM EDT
Allergan (NYSE: AGN) August weekly call option implied volatility is at 35, August and September is at 28; compared to its 52-week range of 20 to 53 into the expected release of Q2 results today.
...
More
